Urothelial carcinoma (UC)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The experimental group: Patients who were initially diagnosed with urothelial carcinoma by clinical imaging (CT or MRI), and planned to undergo surgical treatment, and were finally confirmed as urothelial carcinoma by postoperative pathology. 2. The control group: Non-neoplastic diseases of the urinary system were excluded clinically (imaging and blood tumor markers ).
Exclusion criteria
Exclusion criteria: 1. Experimental group: (1) The patient has contraindications to surgery, so radical surgery cannot be performed to obtain pathology; (2) The patient had a history of bladder cancer, prostate cancer and other malignant tumors of the urinary system; (3) The patient proposed radical bladder resection in the short term and could not complete the follow-up study; (4) The patient refused to sign the informed consent and participate in the clinical study. 2. Control group: (1) Patients with bladder cancer, prostate cancer and other malignant tumors of urinary system; (2) The patient refused to sign the informed consent and participate in the clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Specificity;Positive predictive value;Negative predictive value;Overall consistency; | — |
Countries
China
Contacts
Peking University First Hospital